tea
second
consum
drink
world
benefici
effect
tea
mostli
attribut
catechin
content
black
tea
deriv
leav
camellia
sinensi
plant
rich
theaflavin
polyphenol
particular
theaflavin
digal
vero
cell
use
evalu
effect
purifi
individu
black
tea
theaflavin
antiherp
simplex
viru
agent
rise
hsv
resist
strain
critic
need
develop
novel
antiherpesvir
treatment
result
cytotox
assay
test
mt
show
toxic
vero
cell
concentr
lm
antivir
activ
individu
theaflavin
test
plaqu
reduct
assay
mt
assay
flow
cytometr
analysi
confoc
microscopi
observ
result
show
exhibit
potent
dosedepend
effect
effici
vero
cell
concentr
lm
suffici
inhibit
product
viral
particl
effect
due
direct
effect
virion
treat
vero
cell
h
prior
infect
treat
cell
differ
time
post
infect
inhibit
product
stabl
vagin
ph
indic
potenti
promis
natur
afford
remedi
herp
simplex
viral
infect
herp
simplex
viru
hsv
infect
consid
signific
worldwid
health
concern
main
caus
oral
infect
affect
mouth
lip
mostli
link
genit
herp
estim
approxim
world
popul
seroposit
seroposit
fatahzadeh
schwartz
unit
state
alon
peopl
infect
infect
persist
increas
yearli
new
case
unit
state
fatahzadeh
schwartz
hsv
virus
envelop
doubl
strand
dna
virus
made
kbp
kbp
length
dolan
et
al
hsv
life
cycl
begin
viral
glycoprotein
bind
host
epitheli
cellular
receptor
viral
glycoprotein
gd
main
determin
cellular
bind
fusion
spear
et
al
upon
bind
suitabl
host
cell
receptor
herp
viru
entri
mediat
hvem
heparan
sulfat
hs
gd
form
fusion
complex
gb
gh
gl
complex
allow
viral
envelop
fuse
host
cellular
plasma
membran
consequ
viru
entri
host
cell
spear
et
al
subramanian
geraghti
next
viral
nucleocapsid
transport
host
cell
nucleu
viral
replic
transcript
take
place
garner
outsmart
host
immun
system
viru
also
achiev
latent
stage
infect
neuron
cell
latent
viru
dormant
restimul
lytic
cycl
way
hsv
abl
propag
lifetim
infect
host
kramer
et
al
recent
lot
attent
given
health
properti
found
tea
dufresn
farnworth
sharangi
black
green
oolong
tea
come
plant
camellia
sinensi
black
tea
consum
drink
world
water
green
tea
compris
http
elsevi
bv
right
reserv
oolong
tea
kuroda
hara
black
tea
rich
theaflavin
polyphenol
particular
theaflavin
monogal
digal
fig
li
et
al
black
tea
theaflavin
shown
contain
antioxid
almajano
et
al
anticanc
gosslau
et
al
antiinflammatori
zu
et
al
antimicrobi
almajano
et
al
friedman
antivir
abil
includ
bovin
coronaviru
bovin
rotaviru
clark
et
al
liu
et
al
yang
et
al
influenza
zu
et
al
cantator
et
al
previous
show
antivir
efficaci
major
catechin
constitu
green
tea
epigallocatechin
gallat
egcg
ester
modif
palmitoylegcg
combat
infect
vero
cell
de
oliveira
et
al
crude
black
tea
extract
also
shown
contain
antiherpesvir
activ
theaflavin
may
major
antivir
player
cantator
et
al
want
determin
effect
purifi
individu
black
tea
theaflavin
infect
furthermor
theaflavin
share
mani
structur
characterist
green
tea
catechin
suggest
may
also
effect
compound
hsv
infect
thu
applic
agent
natur
topic
remedi
prevent
treat
infect
spread
promis
green
monkey
kidney
cell
vero
human
lung
adenocarcinoma
epitheli
cell
kindli
provid
dr
sandra
adam
depart
biolog
molecular
biolog
montclair
state
univers
montclair
nj
usa
vero
cell
cultur
confluent
dulbecco
minim
essenti
media
dmem
fetal
bovin
serum
fb
lgml
gentamicin
co
cell
cultur
confluent
ham
k
nutrient
media
kaighn
modif
mm
lglutamin
fb
lgml
gentamicin
co
recombin
strain
express
tegument
protein
gene
fuse
green
fluoresc
protein
gfp
use
viral
assay
willard
passag
viru
perform
flask
cell
allow
reach
complet
cytopath
effect
cpe
media
collect
centrifug
supernat
contain
viru
store
cryogen
vial
lipophil
sephadex
resin
purchas
sigmaaldrich
st
loui
mo
usa
ethyl
acet
aceton
purchas
merck
chemic
co
damstadt
germani
black
tea
crude
extract
powder
theaflavin
obtain
dh
nutraceut
edison
nj
usa
prepar
theaflavin
theaflavinmonogal
digal
specif
theaflavin
obtain
black
tea
crude
extract
extract
isol
describ
previou
studi
lo
et
al
ethyl
acet
fraction
black
tea
crude
extract
subject
column
elut
aceton
solut
distinguish
reddish
color
fraction
aceton
solut
fraction
concentr
rotari
evapor
lyophil
freez
dryer
puriti
least
confirm
hplc
method
li
et
al
purifi
dissolv
dmso
produc
stock
concentr
mm
theaflavin
solut
stock
solut
dilut
media
accordingli
produc
desir
concentr
lm
cell
morpholog
assess
use
amscop
microscop
attach
camera
compar
treat
untreat
sampl
vero
cell
grown
mm
dish
h
treat
lm
theaflavin
h
unadsorb
theaflavin
aspir
cell
wash
pb
fresh
media
ad
dish
cell
examin
morpholog
chang
h
incub
co
vero
cell
plate
well
plate
incub
h
cultur
confluenc
treat
variou
concentr
lm
triplic
h
unadsorb
theaflavin
aspir
fresh
media
ad
well
incub
addit
h
cell
viabilityprolifer
determin
use
tetrazolium
reductionbas
kit
mt
mt
promega
corp
previous
describ
de
oliveira
et
al
cytotox
also
determin
h
treatment
vero
cell
plate
well
plate
concentr
cell
per
ml
volum
per
well
cell
treat
variou
concentr
lm
triplic
dmso
use
control
previous
describ
chiang
et
al
cell
incub
day
co
cellular
toxic
determin
use
mt
kit
describ
antivir
activ
evalu
use
mt
method
vero
cell
plate
well
plate
concentr
x
cell
per
ml
volum
per
well
virion
treat
differ
concentr
lm
h
prior
infect
dmso
use
neg
control
cell
infect
treat
untreat
allow
adsorb
h
co
unadsorb
virion
aspir
cell
overlaid
medium
cell
incub
day
antivir
activ
determin
use
mt
kit
promega
corp
viral
inhibit
rate
calcul
previous
describ
chiang
et
al
viral
titer
determin
use
plaqu
reduct
assay
viral
titer
determin
standard
plaqu
assay
virion
serial
dilut
plate
onto
confluent
plate
vero
cell
plaqu
form
unit
observ
h
later
virion
treat
differ
concentr
lm
h
prior
infect
vero
cell
plate
well
plate
allow
reach
confluenc
cell
infect
treat
untreat
pfuml
serial
dilut
allow
adsorb
h
co
unadsorb
virion
aspir
cell
overlaid
mediumcontain
agar
cell
incub
h
co
fix
formaldehyd
phosphat
buffer
h
plaqu
visual
count
stain
crystal
violet
plaqu
assay
carri
triplic
vero
cell
grown
mm
dish
allow
reach
confluenc
virion
treat
differ
concentr
lm
h
co
prior
infect
cell
infect
treat
untreat
pfuml
h
co
unadsorb
virion
aspir
cell
wash
pb
fresh
media
ad
dish
cell
incub
co
addit
h
cell
trypsin
resuspend
pb
flow
cytometri
analysi
flow
cytometri
antivir
assay
carri
triplic
vero
cell
grown
glass
cover
slip
place
well
plate
h
virion
treat
lm
h
prior
infect
cell
infect
treat
untreat
pfuml
h
co
unadsorb
virion
aspir
cell
wash
pb
fresh
media
ad
well
cell
incub
co
addit
h
cell
stain
nm
dapi
min
room
temperatur
dark
next
cell
fix
acetonemethanol
solut
min
glass
cover
slip
place
glass
slide
glycerol
mount
media
cell
analyz
use
olympu
confoc
laserscan
microscop
clsm
bind
assay
carri
temperatur
allow
virion
bind
cell
receptor
enter
cell
virion
treat
differ
concentr
lm
h
prior
infect
vero
cell
plate
mm
cell
cultur
dish
allow
reach
confluenc
cell
infect
treat
untreat
pfuml
serial
dilut
allow
adsorb
h
unadsorb
virion
aspir
cell
wash
pb
twice
plaqu
reduct
assay
carri
describ
section
bind
assay
carri
triplic
vero
cell
plate
mm
cell
cultur
dish
allow
reach
confluenc
cell
infect
treat
untreat
pfuml
serial
dilut
allow
bind
h
temperatur
virion
bind
cell
receptor
penetr
cell
unbound
virion
aspir
cell
treat
differ
concentr
lm
h
co
temperatur
virion
abl
success
penetr
cell
unadsorb
theaflavin
aspir
cell
wash
pb
twice
plaqu
reduct
assay
carri
describ
section
penetr
assay
carri
triplic
flow
cytometri
bindingadsorpt
studi
vero
cell
grown
mm
dish
allow
reach
confluenc
order
studi
abil
inhibit
bind
adsorpt
viru
cell
treatment
lm
done
differ
time
point
viral
infect
first
virion
pfuml
cell
treat
lm
h
prior
infect
cell
also
treat
h
differ
time
point
post
infect
h
treatment
cell
wash
pb
fresh
media
ad
dish
incub
co
h
post
infect
cell
trypsin
resuspend
pb
flow
cytometri
analysi
assay
perform
triplic
data
analyz
use
one
way
analysi
varianc
anova
p
spss
vero
cell
expos
lm
h
cell
morpholog
analyz
use
phase
contrast
microscopi
h
post
treatment
signific
chang
morpholog
observ
concentr
use
data
shown
thu
treatment
concentr
lm
vero
cell
appear
low
cellular
toxic
determin
whether
vero
cell
viabl
could
prolifer
treat
differ
concentr
h
follow
h
tffree
incub
period
mt
colorimetr
kit
measur
cellular
metabol
use
seen
fig
treatment
cell
lm
significantli
affect
cell
viabilityprolifer
although
cell
respond
theaflavin
treatment
dosedepend
manner
vero
cell
cell
prolifer
inhibit
maximum
lm
lm
lm
exposur
concentr
inhibit
cell
prolifer
less
cell
result
suggest
cellular
exposur
theaflavin
lm
toxic
either
vero
cell
mt
also
use
studi
effect
vero
cell
prolong
exposur
time
day
cytotox
concentr
cc
lm
respect
result
obtain
show
toxic
vero
cell
concentr
lm
even
h
exposur
data
shown
studi
antivir
activ
vero
cell
infect
treat
lm
untreat
h
follow
incub
period
half
maxim
effect
concentr
ec
select
index
si
determin
mt
result
show
three
theaflavin
possess
antivir
activ
ec
lm
si
ec
lm
si
ec
lm
si
base
si
valu
antiherpesvir
activ
theaflavin
order
found
highest
si
valu
plaqu
reduct
assay
flow
cytometri
assay
fluoresc
confoc
microscopi
studi
done
confirm
efficaci
studi
effect
product
viral
plaqu
vero
cell
infect
either
treat
concentr
lm
untreat
seen
fig
effect
three
theaflavin
concentrationdepend
treatment
lm
show
signific
reduct
plaqu
format
exposur
lm
caus
reduct
pfu
vero
cell
cell
respect
exposur
lm
caus
reduct
pfu
vero
cell
respect
exposur
lm
caus
remark
decreas
titer
furthermor
exposur
lm
caus
decreas
titer
vero
cell
exposur
lm
either
express
reduc
viral
titer
exposur
lm
suffici
significantli
inhibit
product
viral
plaqu
fig
plaqu
form
unit
significantli
differ
control
p
collect
result
suggest
nontox
concentr
effect
inhibit
viral
plaqu
format
seem
effect
among
three
antivir
efficaci
also
obtain
flow
cytometri
assay
abil
infect
vero
fig
fig
cell
expos
lm
theaflavin
measur
gfp
intens
level
strain
seen
fig
treat
differ
concentr
lm
df
f
gi
g
jl
j
l
infect
repress
dosedepend
manner
higher
concentr
lower
gfp
express
observ
vero
cell
furthermor
result
flow
cytometri
assay
confirm
effect
theaflavin
infect
vero
cell
effect
result
confirm
lm
suffici
greatli
inhibit
viral
infect
vero
cell
fig
determin
effect
theaflavin
life
cycl
vero
ad
cell
infect
either
treat
lm
h
untreat
fig
express
local
tegumentgfp
observ
use
confoc
microscop
h
post
infect
cell
stain
dapi
cell
nucleu
analyz
potenti
cytopath
effect
upon
infect
tegument
protein
associ
cellular
membran
local
throughout
cytoplasm
distinct
puncta
murphi
et
al
willard
shown
fig
signific
level
express
observ
untreat
control
b
b
dmso
treat
control
c
c
vero
infect
cell
contrarili
lm
treat
infect
cell
show
gfp
posit
granul
instead
close
resembl
uninfect
cell
control
overal
result
indic
treatment
lm
significantli
affect
life
cycl
vero
cell
determin
treatment
lm
disrupt
virion
bind
vero
cellular
receptor
bind
assay
perform
assay
perform
temperatur
allow
viral
bind
cellular
penetr
upon
later
place
cell
virion
abl
penetr
complet
life
cycl
theaflavin
disrupt
viral
bind
consequ
prevent
viral
penetr
plaqu
observ
seen
fig
lm
treatment
vero
infect
cell
suffici
stop
viru
fig
continu
abil
bind
infect
cell
mani
plaqu
seen
cell
infect
untreat
dmso
treat
plaqu
observ
treat
lm
togeth
assay
suggest
halter
abil
complet
lytic
cycl
prevent
bind
vero
cell
determin
treatment
lm
disrupt
cellular
penetr
step
life
cycl
penetr
assay
perform
assay
initi
perform
allow
viral
bind
prevent
cellular
penetr
cell
virion
expos
lm
h
temperatur
virion
penetr
cell
complet
life
cycl
theaflavin
disrupt
viral
penetr
plaqu
observ
seen
fig
substanti
decreas
plaqu
format
vero
cell
accordingli
expos
lm
time
penetr
furthermor
plaqu
seen
lm
treatment
vero
infect
cell
decreas
decreas
plaqu
format
cell
thu
assay
suggest
lm
sever
affect
viral
penetr
concentr
lm
need
significantli
halter
abil
penetr
vero
cell
flow
cytometri
assay
confirm
abil
inhibit
bindingadsorpt
confirm
find
establish
bind
assay
expos
lm
differ
time
point
lytic
cycl
gfp
intens
strain
record
differ
treatment
use
flow
cytomet
vero
fig
fig
infect
cell
preexposur
f
f
exposur
time
h
g
g
lm
h
show
inhibitori
effect
compar
control
viru
infect
vero
cell
b
b
preexposur
lm
vero
cell
h
e
e
exposur
h
hl
h
l
post
infect
h
signific
inhibitori
effect
result
confirm
find
establish
bind
assay
seem
act
directli
viral
particl
hinder
abil
bind
penetr
cell
contrarili
show
inhibitori
effect
viru
alreadi
penetr
cell
constant
attempt
creat
safe
effect
vaccin
hsv
infect
date
littl
signific
achiev
bernstein
stanberri
quenel
et
al
current
treatment
choic
nucleosid
analog
target
viral
dna
polymeras
act
chain
termin
prevent
viru
dna
elong
bradi
bernstein
despit
effect
antivir
therapi
viru
shown
develop
resist
strain
especi
immunocompromis
host
bacon
et
al
viru
acquir
mutat
thymidin
kinas
tk
enzym
andor
viral
dna
polymeras
gene
thu
bypass
antivir
effect
drug
would
produc
bacon
et
al
piret
boivin
therefor
need
new
antivir
treatment
substitut
complement
current
use
antihsv
medicin
antiherpesvir
activ
differ
natur
compound
focu
mani
studi
due
low
toxic
potent
antivir
abil
de
oliveira
et
al
jassim
naji
green
tea
polyphenol
receiv
attent
past
year
data
present
studi
suggest
black
tea
theaflavin
may
better
candid
microbicid
hsv
infect
theaflavin
report
low
cytotox
effect
normal
human
lung
fibroblast
cell
cem
cell
liu
et
al
likewis
show
low
toxic
toward
vero
cell
concentr
lm
recombin
viru
gfp
gene
fuse
tegument
protein
use
studi
serv
valuabl
tool
identifi
green
fluoresc
granul
viral
particl
fluoresc
confoc
microscop
observ
green
fluoresc
protein
also
detect
flow
cytomet
nm
blue
laser
provid
quantit
inform
infect
sever
experiment
approach
use
demonstr
power
inhibitori
effect
lytic
cycl
effect
consist
previou
report
show
black
tea
extract
tf
abl
inhibit
infect
cantator
et
al
report
show
digal
dimer
egcg
potent
inhibitor
hsv
infect
isaac
et
al
seen
treatment
virion
lm
h
remov
h
adsorpt
caus
reduct
infect
vero
cell
measur
plaqu
reduct
assay
fig
flow
cytometri
fig
moreov
bind
penetr
assay
suggest
inhibit
entri
target
cell
interf
bindingadsorpt
virion
cellular
receptor
fig
show
signific
antivir
effect
viru
alreadi
penetr
cell
impli
direct
effect
virion
taken
fact
contact
appropri
cell
hsv
infect
readili
persist
effect
microbicid
abl
target
viru
prior
first
contact
host
cell
thu
seem
ideal
candid
combat
hsv
prior
host
cellular
infect
similar
result
seen
studi
also
target
viral
entri
step
disrupt
glycoprotein
core
structur
summari
result
present
indic
black
tea
theaflavin
strong
inhibitori
effect
vero
infect
cell
display
highest
respons
seen
antivir
assay
conduct
throughout
studi
inhibit
dosedepend
manner
plaqu
reduct
assay
flow
cytometr
antivir
assay
fluoresc
confoc
microscopi
studi
demonstr
exhibit
strongest
effect
result
suggest
explor
potenti
applic
manag
infect
furthermor
major
advantag
use
theaflavin
microbicid
shown
stabl
nonfavor
condit
acid
ph
high
temperatur
high
humid
li
et
al
high
stabil
allow
suitabl
topic
antivir
agent
vagin
ph
jhoo
et
al
addit
recent
studi
shown
combin
lactic
acid
may
effect
way
inactiv
hsv
vagin
area
confirm
result
seen
isaac
xu
final
current
market
antiherpet
medic
highli
costli
make
plausibl
afford
solut
treatment
prevent
hsv
infect
conclus
use
infect
could
signific
health
benefit
futur
studi
focu
better
understand
molecular
mechan
theaflavin
act
anim
model
